You are here

  • Home
  • Archive
  • Volume 24, Issue 3
  • Does Modality of Adjuvant Chemotherapy After Interval Surgical Debulking Matter in Epithelial Ovarian Cancer?: An Exploratory Analysis

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Does Modality of Adjuvant Chemotherapy After Interval Surgical Debulking Matter in Epithelial Ovarian Cancer?: An Exploratory Analysis

Authors

  • Nashmia Joudallah Al Mutairi Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Newborn Care, University of Ottawa, Ottawa, Ontario, Canada. PubMed articlesGoogle scholar articles
  • Tien Le Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Newborn Care, University of Ottawa, Ottawa, Ontario, Canada. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Nashmia Joudallah Al Mutairi, MD, Division of Gynecologic Oncology, Ottawa General Hospital, 501 Smyth Rd—Room 8130, Ottawa, Ontario, Canada K1H 8L6. E-mail: nashmia-j{at}hotmail.com; nalmutairi{at}toh.on.ca.

Citation

Al Mutairi NJ, Le T
Does Modality of Adjuvant Chemotherapy After Interval Surgical Debulking Matter in Epithelial Ovarian Cancer?: An Exploratory Analysis
International Journal of Gynecologic Cancer 2014;24:461-467.

Publication history

  • Received June 5, 2013
  • Accepted November 17, 2013
  • First published March 1, 2014.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2014 by IGCS and ESGO